Redmile Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,205,206
| Closed | -$102M | – | 80 |
|
|
2023
Q1 | $102M | Sell |
4,205,206
-296,905
| -7% | -$7.22M | 4.44% | 3 |
|
|
2022
Q4 | $96.4M | Buy |
4,502,111
+1,102,211
| +32% | +$23.6M | 3.94% | 6 |
|
|
2022
Q3 | $61M | Buy |
3,399,900
+1,881,000
| +124% | +$33.7M | 2.37% | 13 |
|
|
2022
Q2 | $14.6M | Buy |
1,518,900
+33,100
| +2% | +$318K | 0.56% | 44 |
|
|
2022
Q1 | $25M | Sell |
1,485,800
-14,200
| -0.9% | -$239K | 0.78% | 36 |
|
|
2021
Q4 | $25.1M | Buy |
+1,500,000
| New | +$25.1M | 0.57% | 42 |
|
|
2016
Q4 | – | Sell |
-505,154
| Closed | -$23.3M | – | 60 |
|
|
2016
Q3 | $23.3M | Buy |
+505,154
| New | +$23.3M | 1.85% | 20 |
|
|
2014
Q2 | – | Sell |
-19,374
| Closed | -$692K | – | 58 |
|
|
2014
Q1 | $692K | Sell |
19,374
-297,147
| -94% | -$10.6M | 0.08% | 49 |
|
|
2013
Q4 | $10.2M | Buy |
+316,521
| New | +$10.2M | 1.26% | 34 |
|